CRISPR Therapeutics Names A.J. Silver CFO As Raju Prasad Departs
(RTTNews) - CRISPR Therapeutics Inc. (CRSP), a biopharmaceutical company, announced that Chief Financial Officer Raju Prasad, PhD, will step down to pursue other opportunities, and A.J. Silver, currently Senior Vice President of Finance, will succeed him as CFO effective immediat